Protagonist Therapeutics (NASDAQ:PTGX) Given New $54.00 Price Target at HC Wainwright
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its price objective raised by HC Wainwright from $50.00 to $54.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price target would indicate a potential upside of 53.89% from the company’s current price. A number of […]
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its price objective raised by HC Wainwright from $50.00 to $54.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price target would indicate a potential upside of 53.89% from the company’s current price. A number of […]
